Sign In
Buy MRK
$115.17
+0.270 (+0.235%)
At Close: Jun 16, 2026
Merck to Present New Data from HIV Treatment and Prevention Pipeline at European AIDS Conference 2025
07:00am, Thursday, 09'th Oct 2025
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that it will present new findings from its HIV treatment and preve
Merck Advances Oncology Innovation, Highlighting Progress in New Tumor Types and Earlier Stages of Disease at ESMO 2025
06:45am, Thursday, 09'th Oct 2025
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new research from more than 100 abstracts across more than 20 type
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Merck (MRK) To Contact Him Directly To Discuss Their Options If you purchased or acquire
4 Bank of America Strong Buy Growth 10 Stocks That All Pay Dividends
07:17am, Wednesday, 08'th Oct 2025
BofA Securities is the investment banking and capital markets division of Bank of America, one of the largest financial institutions in the United States.
Merck (MRK) Declines More Than Market: Some Information for Investors
06:51pm, Tuesday, 07'th Oct 2025
Merck (MRK) closed the most recent trading day at $87.61, moving 1.34% from the previous trading session.
MRK Expands Tulisokibart Program in Three New Inflammatory Diseases
01:01pm, Tuesday, 07'th Oct 2025
Merck broadens its tulisokibart clinical program with three new phase IIb studies, deepening its reach across immune-mediated inflammatory diseases.
Merck Rises 13% in a Week: Should You Buy, Sell or Hold the Stock?
09:31am, Tuesday, 07'th Oct 2025
MRK's stock witnesses an upside after Pfizer's pricing deal, but Gardasil's slump and Keytruda's looming LOE keep investors cautious.
Merck Completes Acquisition of Verona Pharma
06:45am, Tuesday, 07'th Oct 2025
RAHWAY, N.J.--(BUSINESS WIRE)--Merck Completes Acquisition of Verona Pharma.
How to trade the health care break out
02:24pm, Monday, 06'th Oct 2025
The health care sector up 6.5% in one week. The Investment Committee debate how to trade the space.
My Top 5 Biotech Stocks Big Pharma Could Buy Next
01:29pm, Monday, 06'th Oct 2025
While AI hype reigns on Wall Street, the healthcare sector is still far from the peaks it reached during the COVID-19 pandemic. And what's more important, many of the biotech stocks remain outside of
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced it has initiated three Phase 2b trials evaluating the safety and efficac
The Rotation To Value Is On – 5 October Surprise High-Yield Picks
03:41pm, Sunday, 05'th Oct 2025
An “October Surprise” is usually a significant, late-breaking news event that generally occurs just before a November election and has the potential to influence its outcome.
October Dogs Of The Dow Flash One Ideal 'Safer' Dividend Buy
12:18pm, Saturday, 04'th Oct 2025
Verizon stands out as the only Dow stock meeting the 'dogcatcher' ideal: annual dividends from $1K invested exceed its share price. Analyst forecasts suggest top-ten Dow Dogs could deliver average net
5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% (Oct. 2025)
08:15am, Saturday, 04'th Oct 2025
This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering significant discounts to their historical norms. We go over our filter
Merck: A Race Against The Keytruda Clock
01:21pm, Friday, 03'rd Oct 2025
Merck (MRK) is attractively valued, boasting strong free cash flow, robust margins, and a leading position in oncology with Keytruda. MRK faces a looming patent cliff for Keytruda in 2028, but a stron
